ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,078Medicare Part D Prescriptions Filled, Including Refills

Rank: 59 out of 1290

$597K Total Retail Price of All Prescriptions

Rank: 144 out of 1290

698 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 698 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 698 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 8,287 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 563 456 1 1
LEVOTHYROXINE SODIUM 365 327 2 4
AMLODIPINE BESYLATE 325 271 3 3
LISINOPRIL 322 262 4 5
OMEPRAZOLE 280 236 5 2
METFORMIN HCL 242 170 6 10
METOPROLOL TARTRATE 238 219 7 7
CITALOPRAM HBR 225 197 8 29
GABAPENTIN 210 160 9 8
ZOLPIDEM TARTRATE 199 130 10 15
FLUTICASONE PROPIONATE 184 142 11 26
CRESTOR 182 148 12 17
HYDROCODONE-ACETAMINOPHEN 178 90 S3 13 6
FUROSEMIDE 166 148 14 9
ATENOLOL 157 126 15 18
HYDROCHLOROTHIAZIDE 152 132 16 20
ALENDRONATE SODIUM 144 135 17 39
WARFARIN SODIUM 140 104 18 22
FLUOXETINE HCL 122 85 19 79
PANTOPRAZOLE SODIUM 116 98 20 48
NEXIUM 114 79 21 34
ATORVASTATIN CALCIUM 112 111 22 23
CLOPIDOGREL 109 98 23 24
CARVEDILOL 106 103 24 12
ALPRAZOLAM 104 68 25 47
RANITIDINE HCL 101 59 26 49
METOPROLOL SUCCINATE 100 82 27 14
TRAZODONE HCL 99 48 28 44
LOSARTAN POTASSIUM 98 74 29 19
MELOXICAM 97 84 30 31
OXYCODONE HCL 93 0 S2 31 33
AZITHROMYCIN 91 64 32 61
OXYCODONE HCL-ACETAMINOPHEN 91 22 S2 32 52
DIOVAN HCT 88 76 34 112
TEMAZEPAM 88 87 34 71
GLYBURIDE 85 85 R 36 87
FENTANYL 84 0 S2 37 89
LOVASTATIN 73 69 38 45
TAMSULOSIN HCL 72 72 39 11
OXYCODONE-ACETAMINOPHEN 70 33 S2 40 65
INSULIN SYRINGE 70 45 40 76
PLAVIX 69 57 42 32
FINASTERIDE 68 68 43 40
GLYBURIDE-METFORMIN HCL 66 64 R 44 147
GLIPIZIDE 63 43 45 81
TRAMADOL HCL 63 32 45 25
NIFEDIPINE ER 61 61 47 110
SERTRALINE HCL 60 35 48 36
ENDOCET 59 17 S2 49 236
LANTUS 57 49 50 67
ENALAPRIL MALEATE 57 56 50 62
HYDROMORPHONE HCL 55 0 S2 52 145
ALLOPURINOL 54 53 53 60
FENOFIBRATE 54 40 53 98
CLONIDINE HCL 52 36 55 66
MECLIZINE HCL 52 44 55 159
PRAVASTATIN SODIUM 52 51 55 42
GEMFIBROZIL 51 38 58 210
DIOVAN 51 44 58 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.